Travis Alan Coy - 01 Jan 2025 Form 4 Insider Report for Immunocore Holdings plc (IMCR)

Role
Chief Financial Officer
Signature
/s/ Lily Hepworth, Attorney-in-Fact
Issuer symbol
IMCR
Transactions as of
01 Jan 2025
Net transactions value
$0
Form type
4
Filing time
03 Jan 2025, 16:08:28 UTC
Previous filing
02 Jan 2024
Next filing
19 Feb 2026
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMCR Employee Share Option (Right to Buy) Award $0 +274,033 $0.000000 274,033 01 Jan 2025 Ordinary Shares 274,033 $29.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option award shall vest on January 1, 2026, and 6.25% of the shares subject to the option award shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.